Target intelligence / Profile preview

Chromosome 17 (Chr17)

Target
Chr17
Molecular classification
Genomic structure, Chromatin
01

Overview

Chromosome 17 is one of the 23 pairs of human chromosomes, representing approximately 2.5% to 3% of the total cellular DNA (National Library of Medicine, 2024). It encompasses about 83 million base pairs and encodes over 1,100 genes, many of which are critical in human health and disease (National Human Genome Research Institute, 2024). Key genes located on this chromosome include the tumor suppressor TP53, the DNA repair gene BRCA1, and the oncogene ERBB2 (HER2) (PubMed, 2023). While the chromosome as a whole is not a therapeutic target, its constituent genes and their protein products are central to many drug development efforts, particularly in oncology. Structural variations such as 17p deletions or polysomy 17 serve as vital diagnostic and prognostic biomarkers in clinical practice (StatPearls, 2024). Additionally, mutations in genes like NF1 and MAPT on this chromosome are linked to neurofibromatosis and various tauopathies, respectively (UniProt, 2024). Consequently, while not a "target" in the traditional sense, its genomic integrity is fundamental to cellular homeostasis and therapeutic response.

Other names
Human Chromosome 1717th chromosome
02

Mechanism of action

Not applicable

03

Biological functions

Genetic information storageRegulation of gene expressionDNA replicationMitosis
04

Disease associations

CancerNeurodegenerative diseaseGenetic disorder
05

Safety considerations

Not applicable
06

Biomarkers

17p deletionHER2 amplificationTP53 mutationIsochromosome 17q

Beyond the preview

Go deeper on Chromosome 17 (Chr17).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Chromosome 17 (Chr17).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call